You have 9 free searches left this month | for more free features.

newly diagnosed childhood ependymoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

Recruiting
  • Medulloblastoma
  • +7 more
  • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
  • +2 more
  • Buffalo, New York
  • +2 more
Jul 8, 2022

Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))

Active, not recruiting
  • Malignant Glioma
  • +2 more
  • Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
  • Concurrent Optune and RT followed by Optune System alone
  • Los Angeles, California
  • +8 more
Jan 17, 2023

Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

Recruiting
  • Diffuse Midline Glioma (DMG)
  • +7 more
  • ONC206
  • Standard of Care Radiation Therapy
  • San Francisco, California
  • +2 more
Sep 13, 2022

Diffuse Intrinsic Pontine Glioma, Medulloblastoma, Childhood, Recurrent Trial in Madrid (AloCELYVIR)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Medulloblastoma, Childhood, Recurrent
  • AloCELYVIR
  • Madrid, Spain
    Hospital Infantil Universitario Niño Jesús
Sep 29, 2022

Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,

Active, not recruiting
  • Adult Anaplastic Astrocytoma
  • +15 more
  • biopsy
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic
Apr 8, 2022

Anaplastic Ependymoma, Brain Ependymoma, Cellular Ependymoma Trial in Worldwide (radiation, drug, other)

Active, not recruiting
  • Anaplastic Ependymoma
  • +5 more
  • 3-Dimensional Conformal Radiation Therapy
  • +7 more
  • Birmingham, Alabama
  • +208 more
Mar 7, 2022

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Orange, Chicago, Boston (rHSC-DIPGVax,

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • rHSC-DIPGVax
  • +2 more
  • Orange, California
  • +2 more
Nov 10, 2022

Childhood Favorable Prognosis Hodgkin Lymphoma, Childhood Lymphocyte Depletion Hodgkin Lymphoma, Childhood Mixed Cellularity

Completed
  • Childhood Favorable Prognosis Hodgkin Lymphoma
  • +5 more
  • radiation therapy
  • +11 more
  • Arcadia, California
    Children's Oncology Group
Mar 26, 2021

Ependymoma, Recurrent Childhood, Ependymoma Trial in Denver, Orlando (Granulocyte Macrophage Colony Stimulation Factor)

Active, not recruiting
  • Ependymoma, Recurrent Childhood
  • Ependymoma
  • Granulocyte Macrophage Colony Stimulation Factor
  • Denver, Colorado
  • +1 more
Feb 8, 2022

Down Syndrome, Acute Lymphoblastic Leukemia, Childhood Cancer Trial in Worldwide (Daunorubicin, Prednisolone, Vincristine)

Recruiting
  • Down Syndrome
  • +2 more
  • Shatin, New Territories, Hong Kong
  • +9 more
Sep 26, 2022

Glioblastoma Multiforme, Astrocytoma, Grade III, Anaplastic Ependymoma Trial in Chicago (biological, procedure, radiation)

Terminated
  • Glioblastoma Multiforme
  • +4 more
  • Heat Shock Protein Peptide Complex-96 (HSPPC-96)
  • +2 more
  • Chicago, Illinois
    Ann & Robert H. Lurie Children's Hospital of Chicago
Jul 24, 2020

Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +9 more
  • DNA analysis
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 28, 2021

Radioresistance of Ependymomas in Children and Adolescents

Recruiting
  • Ependymoma of Brain
  • Pediatric Solid Tumor
    • Toulouse, France
      Institut Claudius Regaud
    Dec 8, 2021

    The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding

    Completed
    • Leukemia, Acute
      • (no location specified)
      Jul 23, 2023

      Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)

      Active, not recruiting
      • Brain and Central Nervous System Tumors
      • Induction Chemotherapy
      • +3 more
      • Palo Alto, California
      • +5 more
      Nov 29, 2022

      Leukemia, Juvenile Myelomonocytic, JMML, JCML Trial (Trametinib, Azacitidine, Fludarabine)

      Not yet recruiting
      • Leukemia, Juvenile Myelomonocytic
      • +4 more
      • (no location specified)
      May 4, 2023

      Childhood Acute Promyelocytic Leukemia (M3), Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Trial in

      Active, not recruiting
      • Childhood Acute Promyelocytic Leukemia (M3)
      • Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
      • arsenic trioxide
      • +7 more
      • Birmingham, Alabama
      • +110 more
      Mar 23, 2022

      CNS Tumor, Pediatric, Chemo-induced Nausea and Vomiting, Child Solid Tumor Trial in Canada, United States (Real Acupressure

      Completed
      • Central Nervous System Tumor, Pediatric
      • +2 more
      • Real Acupressure Band
      • Placebo Acupressure Band
      • Long Beach, California
      • +24 more
      Jul 19, 2021

      Childhood Rheumatic Diseases Trial in Istanbul (Panoramic rad.)

      Not yet recruiting
      • Childhood Rheumatic Diseases
      • Panoramic rad.
      • Istanbul, Turkey
        Ecem Ipek
      Apr 26, 2023

      Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)

      Recruiting
      • Leukemia, Monocytic, Acute
      • Pediatric AML
      • Foshan, Guangdong, China
      • +8 more
      Mar 28, 2022

      Brain Stem Glioma, Cerebral Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma Trial in Canada, United States

      Active, not recruiting
      • Brain Stem Glioma
      • +4 more
      • Bevacizumab
      • +2 more
      • Birmingham, Alabama
      • +136 more
      Oct 15, 2022

      Ovarian Reserve in Younger Newly Diagnosed Lymphomas

      Active, not recruiting
      • Anaplastic Large Cell Lymphoma
      • +4 more
      • Laboratory Biomarker Analysis
      • Questionnaire Administration
      • Birmingham, Alabama
      • +106 more
      Jan 11, 2023

      Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

      Active, not recruiting
      • Anaplastic Astrocytoma
      • +2 more
      • Radiation Therapy
      • +2 more
      • Birmingham, Alabama
      • +162 more
      Dec 30, 2022

      Idiopathic Nephrotic Syndrome Trial in United States (Standard of Care, UrApp)

      Recruiting
      • Idiopathic Nephrotic Syndrome
      • Standard of Care
      • UrApp
      • Atlanta, Georgia
      • +3 more
      Jul 14, 2022